DELAYED DEVELOPMENT OF HYPERTENSION AFTER SHORT-TERM NITRENDIPINE TREATMENT

被引:51
|
作者
RIZZONI, D [1 ]
CASTELLANO, M [1 ]
PORTERI, E [1 ]
BETTONI, G [1 ]
MUIESAN, ML [1 ]
ROSEI, EA [1 ]
机构
[1] UNIV BRESCIA, CATTEDRA SEMEIOT & METODOL MED SCI MED, I-25100 BRESCIA, ITALY
关键词
CALCIUM CHANNEL BLOCKERS; VASCULAR RESISTANCE; HYPERTROPHY; NOREPINEPHRINE; NITRENDIPINE; RATS; INBRED SHR; ACETYLCHOLINE; ENDOTHELIUM;
D O I
10.1161/01.HYP.24.1.131
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In this study we evaluated the delayed effects of a calcium entry blocker on blood pressure and on vascular structural and functional alterations in mesenteric resistance arteries of spontaneously hypertensive rats (SHR). The calcium entry blocker nitrendipine was administered (30 mg/kg per day) according to three different schedules: in one group of SHR from 4 to 8 weeks of age (n=12), in a second group from 8 to 12 weeks of age (n=12), and in a third group from 4 to 12 weeks of age (n=12). Twelve untreated SHR and 12 untreated Wistar-Kyoto rats served as controls. Half the animals of each group were killed at 13 weeks, and the remaining were killed at 38 weeks. After death, relative left ventricular mass was calculated. Vascular morphology and function (responses to norepinephrine and acetylcholine) in mesenteric small arteries were then assessed using a micro-myographic technique. Nitrendipine treatment delayed the development of hypertension and determined the regression of structural alterations of mesenteric resistance arteries in SHR. These favorable effects were maintained for several weeks after treatment withdrawal, provided that treatment was started at 4 weeks of age. Considering the functional alterations of mesenteric arteries in SHR (responses to norepinephrine and acetylcholine), nitrendipine treatment determined an improvement of both these dysfunctions as long as reductions of the media-to-lumen ratio and blood pressure, respectively, were maintained.
引用
收藏
页码:131 / 139
页数:9
相关论文
共 50 条
  • [31] SHORT-TERM TREATMENT OF ALCOHOLICS
    LITTMAN, G
    SOCIAL WORK, 1963, 8 (01) : 120 - 121
  • [32] SHORT-TERM TREATMENT OF ENURESIS
    STANTON, HE
    AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 1979, 22 (02) : 103 - 107
  • [33] Short-term dexamethasone treatment
    W. P. Vandertop
    Child's Nervous System, 2006, 22 : 102 - 102
  • [34] Short-term treatment with lansoprazole
    Dhar, A
    Gupta, VK
    Srinivasan, S
    Sharma, MP
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (10): : 2251 - 2251
  • [35] SHORT-TERM BLOOD PRESSURE VARIABILITY IS REDUCED AFTER NEBIVOLOL COMPARED TO IRBESARTAN TREATMENT IN PATIENTS WITH INTRADIALYTIC HYPERTENSION
    Loutradis, C.
    Bikos, A.
    Aggeloudi, E.
    Raptis, V.
    Faitatzidou, D.
    Theodorakopoulou, M.
    Intzevidou, E.
    Panagoutsos, S.
    Pasadakis, P.
    Zebekakis, P.
    Liakopoulos, V.
    Papagianni, A.
    Parati, G.
    Sarafidis, P.
    JOURNAL OF HYPERTENSION, 2019, 37 : E80 - E81
  • [36] SHORT-TERM BLOOD PRESSURE VARIABILITY IS REDUCED AFTER NEBIVOLOL COMPARED TO IRBESARTAN TREATMENT IN PATIENTS WITH INTRADIALYTIC HYPERTENSION
    Loutradis, Charalampos
    Bikos, Athanasios
    Angeloudi, Elena
    Raptis, Vassilios
    Faitatzidou, Danae
    Theodorakopoulou, Marietta
    Intzevidou, Elena
    Panagoutsos, Stylianos
    Pasadakis, Ploumis
    Zebekakis, Pantelis
    Liakopoulos, Vassilios
    Papagianni, Aikaterini
    Parati, Gianfranco
    Sarafidis, Pantelis
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 382 - 382
  • [37] Short-term treatment of severe hypertension of pregnancy: prospective comparison of nicardipine and labetalol
    S. Elatrous
    S. Nouira
    L. Ouanes Besbes
    S. Marghli
    M. Boussarssar
    M. Sakkouhi
    F. Abroug
    Intensive Care Medicine, 2002, 28 : 1281 - 1286
  • [38] HEMODYNAMIC-EFFECTS OF SHORT-TERM TREATMENT WITH BOPINDOLOL IN ESSENTIAL-HYPERTENSION
    FITSCHA, P
    MEISNER, W
    BRANDSTETTER, G
    TISO, B
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 34 (04) : 411 - 413
  • [39] Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension
    Zacharieva, S
    Atanassova, I
    Natchev, E
    Orbetzova, M
    Tzingilev, D
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (03): : 153 - 156
  • [40] Short-term trends in the prevalence, awareness, treatment, and control of arterial hypertension in Peru
    David Villarreal-Zegarra
    Rodrigo M. Carrillo-Larco
    Antonio Bernabe-Ortiz
    Journal of Human Hypertension, 2021, 35 : 462 - 471